ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Seattle Institute For Biomedical And Clinical Research

Official 2024 U.S. DOL Form 5500 summary for Seattle Institute For Biomedical And Clinical Research (Seattle Institute For Biomedical And Clinical Research 403(b) Dc Plan · EIN 91-1452438 · PN 001): $20.61M net assets, 115 active participants, and $27.21 per $10,000 (27.21 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorSeattle Institute For Biomedical And Clinical Research
Filing IdentifierSeattle Institute For Biomedical And Clinical Research 403(b) Dc Plan · EIN 91-1452438 · PN 001
Plan Category & State403(b) Tax-Exempt DC (WA)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$20.61M
Active Participants115
Direct Admin Fee Rate$27.21 per $10,000 (27.21 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderUsi Advisors, INC.
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI